ObserVa, Switzerland


Senior quadrilingual consultant with 10 years of experience in the pharmaceutical industry. Focused on strategy and investment (biotech/biosimilars/generics) and follow macro-economic trends and how they impact the pharmaceutical industry.

Expert in research and valuation of the global healthcare sector:

  • Projections / Due Diligence
  • Project in Equity Capital Markets
  • Forecasting / Market Segmentation Analysis
  • Competitive Intelligence
  • Scenario Planning and Analysis


Register for the Biosimilars LatAm – Europe 2023